Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.01 (-1.22%)
Close on Nov 13, 2026Market cap $3.53MP/E –Yield –
Imunon ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Imunon's ebitda for the twelve months ending Dec 31, 2022 was -$24.72M. For fiscal 2024 it was -$18.89M. The highest annual figure on record is -$15.07M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$18.89M | – |
| FY2023 | Dec 31, 2023 | -$20.78M | – |
| FY2022 | Dec 31, 2022 | -$24.72M | – |
| FY2021 | Dec 31, 2021 | -$20.30M | – |
| FY2020 | Dec 31, 2020 | -$17.74M | – |
| FY2019 | Dec 31, 2019 | -$19.84M | – |
| FY2018 | Dec 31, 2018 | -$20.71M | – |
| FY2017 | Dec 31, 2017 | -$17.92M | – |
| FY2016 | Dec 31, 2016 | -$19.63M | – |
| FY2015 | Dec 31, 2015 | -$20.42M | – |
| FY2014 | Dec 31, 2014 | -$24.35M | – |
| FY2013 | Dec 31, 2013 | -$15.07M | – |
| FY2012 | Dec 31, 2012 | -$21.86M | – |
| FY2011 | Dec 31, 2011 | -$22.85M | – |
| FY2010 | Dec 31, 2010 | -$19.47M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$7.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.81M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.67M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.90M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.88M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.19M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.97M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.58M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.21M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.66M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.94M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.92M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.19M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.64M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.23M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.23M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.65M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.47M | – |
| Q2 FY2016 | Jun 30, 2016 | -$4.62M | – |
See a number that looks wrong?